December 12, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 3555 companies with "abnormal" market making, 1537 companies with positive Friction Factors and 4922 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Monday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. FUELCELL ENERGY INC (NASDAQ:FCEL), RADVISION LTD (NASDAQ:RVSN), Sun Healthcare Group Inc (NASDAQ:SUNH), OXIGENE INC (NASDAQ:OXGN), WIRELESS RONIN TECHNOLOGIES (NASDAQ:RNIN), ALIMERA SCIENCES INC (NASDAQ:ALIM). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     FCEL       $0.140       14.74%       2,546,686       57.87%       1,802,689       40.97%       743,997         53,143  
     RVSN       $1.170       16.14%       169,797         56.58%       128,188         42.72%       41,609          356     
     SUNH       $0.550       17.52%       591,702         54.00%       500,168         45.65%       91,534          1,664   
     OXGN       $0.190       18.81%       2,418,790       53.27%       2,122,947       46.75%       295,843         15,571  
     RNIN       $0.140       13.21%       50,710          59.23%       34,900          40.77%       15,810          1,129   
     ALIM       $0.390       27.86%       880,899         53.16%       776,055         46.83%       104,844         2,688

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows FCEL with a dollar gain Monday of $0.14000 and a Friction Factor of 53,143 shares. That means that it only took 53,143 more shares of buying than selling to move FCEL higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

FUELCELL ENERGY INC (NASDAQ:FCEL) - FuelCell Energy, Inc. engages in the development and manufacture of fuel cell power plants for electric power generation primarily in the United States, Canada, Germany, Japan, and South Korea. Its core carbonate fuel cell products include Direct FuelCell or DFC Power Plants for stationary power generation applications. The company also develops carbonate fuel cell and planar solid oxide fuel cell technology. Its proprietary carbonate DFC power plants electrochemically produce electricity directly from readily available hydrocarbon fuels, such as natural gas and biogas fuels. The company serves manufacturers; mission critical institutions, including correction facilities and government installations; and hotels and customers, such as breweries, food processors, and wastewater treatment facilities, who use renewable gas for fuel. FuelCell Energy, Inc. was founded in 1969 and is headquartered in Danbury, Connecticut.

RADVISION LTD (NASDAQ:RVSN) - RADVISION Ltd. engages in the design, development, and supply of products and technology that enable real-time voice, video and data communications over packet and mobile third generation (3G) networks, including the Internet and other networks based on the Internet Protocol (IP). The companys Networking Business Unit offers multimedia communication and videoconferencing network solutions for IP, ISDN, H.323, SIP, and 3G based networks. It provides SCOPIA, an infrastructure solution that includes network infrastructure solutions, endpoint solutions, and management software. This segment also offers SCOPIA Video Infrastructure, a visual communication infrastructure solution used in conferencing for enterprise and service provider environments; SCOPIA Video Conferencing Clients, a HD video conferencing endpoints for personal and group use at the desktop, on the road, in the conference room, or the board room; and SCOPIA Management Suite, a family of management, control, and scheduling applications that provides network management and conference scheduling. Its Technology Business Unit offers voice and video over IP and 3G development toolkits. This segment provides protocol development tools and platforms, as well as associated solutions, such as testing platforms and IP phone toolkits, which enable equipment vendors and service providers to develop and deploy new IP and 3G-based converged networks, services, and technologies. The company also offers various customer care, support, and software development services, as well as professional services, including consulting, development, customization, and system integration. It sells its products worldwide through direct sales channels, as well as through original equipment manufacturers, system integrators, and value added resellers. The company was founded in 1992 and is headquartered in Tel Aviv, Israel.

Sun Healthcare Group Inc (NASDAQ:SUNH) - Sun Healthcare Group, Inc., through its subsidiaries, provides health care services primarily for senior population in the United States. The companys Inpatient Services segment operates skilled nursing centers, assisted and independent living centers, and mental health centers that provide services for individuals requiring assistance for activities in daily living. The skilled nursing centers provide daily nursing, therapeutic rehabilitation, social services, housekeeping, nutrition, and administrative services; assisted living centers offer minimal nursing assistance, housekeeping, nutrition, laundry, and administrative services; independent living centers provide security, housekeeping, nutrition, and limited laundry services; and mental health centers offer a range of inpatient and outpatient behavioral health services for adults and children through specialized treatment programs. It also provides hospice services, including palliative care, social services, pain management, and spiritual counseling. As of December 31, 2010, this segment operated 164 skilled nursing centers; 16 combined skilled nursing, assisted, and independent living centers; 10 assisted living centers; 2 independent living centers; and 8 mental health centers with an aggregate of 23,053 licensed beds in 25 states. Its Rehabilitation Therapy Services segment offers various rehabilitation therapy services, including speech pathology, physical therapy, and occupational therapy for approximately 508 centers in 36 states. The companys Medical Staffing Services segment provides licensed therapists in the areas of physical, occupational, and speech therapy; nurses; pharmacists, pharmacist technicians, and medical imaging technicians; physicians; and related medical personnel. It serves skilled nursing centers, schools, and prisons in 36 states. Sun Healthcare Group, Inc. was founded in 1989 and is based in Irvine, California.

OXIGENE INC (NASDAQ:OXGN) - OXiGENE, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat cancer and eye diseases in the United States. It primarily focuses on the development of product candidates that disable and destroy abnormal blood vessels that provide solid tumors a means of growth and survival, as well as associate with visual impairment in various ophthalmological diseases and conditions. The companys products include ZYBRESTAT, which is in FALCON Trial - Phase II randomized controlled study for the treatment of 1st-line non-small cell lung cancer, as well as in Phase II Simon two-stage design study for the treatment of platinum-resistant ovarian cancer; and OXi4503 that is in Phase I dose-escalation study and Phase Ib dose-ranging study for the treatment of refractory solid tumors hepatic tumors. Its products also include ZYBRESTAT for ophthalmology, which is in phase II randomized, double-masked, placebo-controlled, and single-dose study for proof-of-mechanism study in polypoidal choroidal vasculopathy. OXiGENE has a strategic collaboration agreement with Symphony Capital Partners, L.P. to support the advancement of ZYBRESTAT for oncology and ophthalmology, and OXi4503. The company was founded in 1988 and is headquartered in South San Francisco, California.

WIRELESS RONIN TECHNOLOGIES (NASDAQ:RNIN) - Wireless Ronin Technologies, Inc. provides dynamic digital signage software and service solutions for certain retail and service markets. The company offers RoninCast, an enterprise, Web-based, or hosted content delivery system that manages, schedules, and delivers digital content over wireless or wired networks. It also offers project planning, design, network deployment, software training, equipment, hardware configuration, content engineering/development, implementation, maintenance, and help desk support services, as well as network operations center. In addition, Wireless Ronin Technologies develops e-learning solutions, which are software-based instructional systems for customers primarily in sales force training applications; e-performance support systems that are interactive systems used to increase product literacy of customer sales staff; and e-marketing products to increase customer knowledge of and interaction with customer products. It markets and sells its software and service solutions through direct sales force and resellers in North America. The company was incorporated in 2000 and is headquartered in Minnetonka, Minnesota.

ALIMERA SCIENCES INC (NASDAQ:ALIM) - Alimera Sciences, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of ophthalmic pharmaceuticals. It develops pharmaceuticals for diseases affecting the back of the eye or retina. The companys product candidates include Iluvien, an intravitreal insert that provides a sustained therapeutic effect for up to 36 months in the treatment of diabetic macular edema; or DME, a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness, as well as other ophthalmic diseases, such as the wet form of age-related macular degeneration (AMD), the dry form of AMD, and retinal vein occlusion. It also conducts testing on two classes of Nicotinamide Adenine Dinucleotide Phosphate oxidase inhibitors. The company was founded in 2003 and is headquartered in Alpharetta, Georgia.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net